Lyn Pharma Llp - Due diligence report
A 360° intelligence report on Lyn Pharma Llp: trust score, financial health, credit view, compliance, directors, growth and distress signals…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Lyn Pharma Llp — 360° Intelligence Report
Generated from MCA filings & public recordsLyn Pharma Llp is assessed as Low Risk with a Trust Score of 80/100. Lyn Pharma Llp is an active limited liability partnership incorporated in 2017, operating in the Business Services sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.
Report generated on 11 Oct 2026 from the latest processed filings. Lyn Pharma Llp snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
No processed financialsCredit & Compliance Intelligence
Why the scores are what they are- Financial statements needed for a credit view.
Charges position: 0 open (-) · 0 satisfied (-).
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2019 - filings overdue.
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| RAHUL VISHWASRAO KADAM | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| AKASH RAJENDRAKUMAR ANAND | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Ownership & Group Intelligence
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 80Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- No financials on record - ask for audited statements.
- No filed financials - rely on banking statements and GST data.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Request management accounts - public filings insufficient.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 5 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Mane Iot Technologies Private Limited | U74999PN2017PTC170173 | Pune, Maharashtra |
| Id4 Consultancy Private Limited | U74999PN2016PTC165910 | Pune, Maharashtra |
| Samrudhi Enviro Solutions India Private Limited | U29300PN2021PTC204786 | Pune, Maharashtra |
| Jay Vijay Tours & Travels Private Limited | U63030PN2014PTC150505 | Pune, Maharashtra |
| ENLIVEN PROTO MS LLP | AAZ-8048 | Pune, Maharashtra |
| Asset Housing And Realtors Private Limited | U45200PN2015PTC153701 | Pune, Maharashtra |
| CRDIND SERVICES LLP | AAZ-8387 | Pune, Maharashtra |
| Varvenco Recycle Tech Private Limited | U14109PN2023PTC225665 | Pune, Maharashtra |
| Learnedge Solutions Private Limited | U80903PN2022PTC208703 | Pune, Maharashtra |
| Globuzz Media Private Limited | U74999PN2021PTC201433 | Pune, Maharashtra |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Lyn Pharma Llp before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Lyn Pharma Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Lyn Pharma Llp - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Lyn Pharma Llp pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Lyn Pharma Llp - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Lyn Pharma Llp an active company?
Lyn Pharma Llp has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Lyn Pharma Llp financially healthy?
Processed financial statements are not yet available for Lyn Pharma Llp, so its financial health is unassessed.
Should I do business with Lyn Pharma Llp?
Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Lyn Pharma Llp?
See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.
Does Lyn Pharma Llp have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Lyn Pharma Llp up to date with its ROC filings?
Last balance sheet is for Mar 2019 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Lyn Pharma Llp?
Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.